Beyhan Ataseven

11PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsRehabilitation engineeringMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 25, 2024
Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial.

Giorgio Valabrega, Matthew A Powell, Sakari Hietanen

|May 13, 2023
Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients.

Majdi Imterat, Philipp Harter, Kerstin Rhiem

|Feb 11, 2023
Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer.

Florian Heitz, Beyhan Ataseven, Claudia Staniczok

|Dec 29, 2022
Ovarian cancer onset across different <i>BRCA</i> mutation types: a view to a more tailored approach for <i>BRCA</i> mutated patients.

Claudia Marchetti, Beyhan Ataseven, Chiara Cassani

|Aug 26, 2022
Satisfaction and Quality of Life of Healthy and Unilateral Diseased <i>BRCA1/2</i> Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire.

Natalie Herold, Martin Hellmich, Frank Lichtenheldt

|Feb 15, 2022
Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial.

Bernd Gerber, Andreas Schneeweiss, Volker Möbus

Pageof 2

Frequent Collaborators

4 joint publications

Kerstin Rhiem

3 joint publications

Florian Heitz

1 joint publications

Birgid Schömig-Markiefka

1 joint publications

Udo Siebolts